Skip to main content
Premium Trial:

Request an Annual Quote

AutoGenomics Pockets $12M in VC Cash; Will Expand Manufacturing, S&M

NEW YORK (GenomeWeb News) — AutoGenomics has hauled in $12 million through a Series C round of private-equity financing from non-institutional investors, the company said today.
 
President Fareed Kureshy said the company will use the cash to “extend our test application menu, expand manufacturing and increase our sales and marketing efforts” for its Infiniti film-based microarray system.
 
The assays are designed to help diagnose clotting disorder thrombophilia.
 
Kureshy said the company does not expect to require more funding for continued growth because its coagulation Factor II and V in vitro diagnostic tests and its analyzer were recently cleared by the US Food and Drug Administration.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.